The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension

Anesthesia and Analgesia

Volumn 93, Issue 6, 2001, Pages 1439-1445

  Haraldsson, Åsa ^a   Kieler Jensen, Niels ^a   Ricksten, Sven Erik ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP PHOSPHODIESTERASE; MILRINONE; PHOSPHODIESTERASE INHIBITOR; PROSTACYCLIN; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; DOSE RESPONSE; DRUG MIXTURE; DRUG POTENTIATION; FEMALE; HEART RIGHT VENTRICLE FAILURE; HEART SURGERY; HUMAN; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VEIN; SYSTEMIC VASCULAR RESISTANCE; VEIN DILATATION;

EID: 0035197129     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200112000-00018     Document Type: Article

References (24)

1. Pulmonary vascular resistance and the risk of heart transplantation
2. A comparison of prostacyclin and sodium nitroprusside for the treatment of heart failure following heart surgery
3. Vasodilator therapy after heart transplantation: Effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1 and sodium nitroprusside
4. Nitric oxide: Physiology, pathophysiology and pharmacology
5. Biology and therapeutic potential of prostacyclin
6. Inhaled nitric oxide: Selective pulmonary vasodilation in cardiac surgical patients
7. Inhaled nitric oxide: Basic biology and clinical applications
8. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome
9. Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: A pharmacodynamic study
10. An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension
11. Positive inotropic and vasodilator action of milrinone in patients with severe congestive heart failure
12. Effects of variable dose milrinone in patients with low cardiac output after cardiac surgery
13. Correction for cumulative type I error
14. Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients
15. Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension
16. Selective pulmonary vasodilation induced by aerosolized zaprinast
17. Pulmonary deposition of a nebulized aerosol during mechanical ventilation
18. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance
19. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome
20. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension
21. Aerosolized prostacyclin and inhaled nitric oxide in septic shock - Different effects on splanchnic oxygenation?
22. Inhalation of prostacyclin (PGI2) for 8 hours does not produce signs of acute pulmonary toxicity in healthy lambs
23. Inhaled prostacyclin and platelet function after cardiac surgery and cardiopulmonary bypass
24. The effects of milrinone on platelets in patients undergoing cardiac surgery